Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)

Lookup NU author(s): Dr Aaron Wetten, Professor David Jones, Dr Jess Dyson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.Introduction: Generic fibrates are used off-label as add-in therapy for the management of primary biliary cholangitis (PBC) but with unproven long-term liver-related survival benefits. The recently developed fibrate, seladelpar, has shown promising results in clinical trials, but these outcomes have been previously marred by safety concerns. Areas covered: We summarize existing treatment options in PBC and evaluate current trial data for seladelpar in relation to liver biochemistry, symptomology, and safety. Expert opinion: Seladelpar leads to marked improvement in liver biochemistry and may improve symptoms. Safety concerns around liver toxicity appear to have been addressed. With likely increasing evidence compared to existing off-label fibrates, seladelpar has the potential as an attractive future second-line agent in PBC.

Publication metadata

Author(s): Wetten A, Jones DEJ, Dyson JK

Publication type: Review

Publication status: Published

Journal: Expert Opinion on Investigational Drugs

Year: 2022

Volume: 31

Issue: 10

Pages: 1101-1107

Online publication date: 04/10/2022

Acceptance date: 27/09/2022

ISSN (print): 1354-3784

ISSN (electronic): 1744-7658

Publisher: Taylor and Francis Ltd.

URL: https://doi.org/10.1080/13543784.2022.2130750

DOI: 10.1080/13543784.2022.2130750

PubMed id: 36194037

Share